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RESUMO 
Introdução: A fluidoterapia agressiva é frequentemente sugerida no tratamento da pancreatite aguda. No entanto, há alguma 
controvérsia sobre o efeito desta opção relativamente ao aparecimento de complicações clínicas e à necessidade de cirurgia. 
Objetivos: Explorar a relação entre administração de fluidos nas primeiras 48 horas e o desenvolvimento de complicações, locais ou 
sistémicas, a fim de contribuir para esclarecer algumas questões nesta matéria. 
Métodos: Este estudo é baseado em registros de 109 pacientes internados na Unidade de Cuidados Cirúrgicos Intermédios do Centro 
Hospitalar Tondela Viseu, entre 2007 e 2012, com diagnóstico de pancreatite aguda. Foi feita a exploração dos dados e aplicados testes 
estatísticos de modo a identificar variáveis que diferenciavam pacientes com complicações. As curvas ROC (Receiver Operating 
Characteristic) permitiram relacionar a quantidade de fluidos administrados nas primeiras 48h com a ocorrência de cada complicação. 
Modelos de regressão logística foram utilizados para identificar fatores de risco independentes para cada complicação. 
Resultados: Não se registou relação significativa entre a terapia de fluidos às 48 horas com a morte nem com a ocorrência de 
complicações sistémicas. Ao contrário, a fluidoterapia às 48 horas revelou-se associada a complicações locais e tardias, presença de 
infeção e necessidade de cirurgia. 
Conclusões: Níveis elevados de fluidos administrados nas primeiras 48 horas registaram-se associados ao desenvolvimento de 
complicações. 
 
Palavras-chave: Pancreatite aguda; Fluidoterapia; Complicações; Curvas ROC; Regressão logística 
 
ABSTRACT 
Introduction: Aggressive fluid therapy is frequently suggested in the treatment of acute pancreatitis. However, there is some 
controversy about the effect of this therapy concerning the development of clinical complications and the need for surgery. 
Objectives: To explore the relationship between fluid administration in the first 48 hours and the development of local or systemic 
complications, to contribute to clarifying some open questions on this subject. 
Methods: This study is based on records of 109 patients admitted to the Surgical High Dependency Unit of Tondela Viseu Hospital 
Centre, between 2007 and 2012, with the diagnosis of acute pancreatitis. Data were explored, and statistical tests were used to 
identify variables that differentiate patients with complications. Receiver operating characteristic (ROC) curves allowed to relate the 
amount of fluids at 48 hours with the occurrence of each complication. Logistic regression models were used to identify independent 
risk factors for each complication. 
Results: There was no significant relationship between fluid therapy at 48 hours with death nor with the occurrence of systemic 
complications. As opposed, fluid therapy at 48 hours revealed to be associated with local and late complications, presence of infection 
and need for surgery. 
Conclusion: High levels of fluid therapy in the first 48 hours were associated with the development of complications. 
 
Keywords: Acute pancreatitis; Fluidotherapy; Complications; ROC curves; Logistic regression. 
 
RESUMEN 
Introducción: La fluidoterapia agresiva se sugiere con frecuencia en el tratamiento de la pancreatitis aguda. Sin embargo, existe cierta 
controversia sobre el efecto de esta terapia con respecto al aumento/reducción de complicaciones clínicas y la necesidad de cirugía. 
Objetivos: Explorar la relación entre la administración de fluidos en las primeras 48 horas y el desarrollo de complicaciones locales y 
sistémicas, con el fin de contribuir a aclarar algunas preguntas abiertas en este tema 
Métodos: Este estudio se basa en los registros de 109 pacientes ingresados en la Unidad de Cuidados Intermedios Quirúrgicos del 
Centro Hospitalario Tondela Viseu, entre 2007 y 2012, con diagnóstico de pancreatitis aguda. Se exploraron los datos y se utilizaron 
pruebas estadísticas para identificar las variables que diferencian a los pacientes con complicaciones. Las curvas ROC (Receiver 
Operating Characteristic) permiten relacionar la cantidad de fluidos a las 48 horas con la aparición de cada complicación. Se usaron 
modelos de regresión logística para identificar factores de riesgo independientes para cada complicación. 
Resultados: No hubo una relación significativa entre la fluidoterapia a las 48 horas con la muerte ni con la aparición de complicaciones 
sistémicas. Por el contrario, la fluidoterapia a las 48 horas reveló estar asociada con complicaciones locales y tardías, presencia de 
infección y necesidad de cirugía. 
Conclusións: Los altos niveles de fluidoterapia en las primeras 48 horas se asociaron con el desarrollo de complicaciones. 
 
Palavras Clave: Pancreatitis aguda; Terapia de fluidos; Complicaciones; Curvas ROC; Regresión logística. 
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INTRODUCTION 
The pancreas is a solid organ located in the upper abdomen, behind the stomach, responsible for a double function, both 
endocrine and exocrine (see, e.g., Blumgart, 2016). Its main endocrine purpose is regulation of blood glucose levels. To put 
through its exocrine function, the pancreas produces a series of digestive enzymes, capable of digesting sugars, lipids, and 
proteins. The premature activation of these enzymes within the pancreatic parenchyma produces a disease called acute 
pancreatitis. The cause of the enzyme activation is diverse (direct toxicity – ethanol, duct hypertension – cholelithiasis (Pollock, 
1959), for example), but once triggered, initiates a cascade reaction that leads to self-digestion of the organ. The degree of initial 
inflammatory response will determine the severity of the disease and the autodigestion (Glasbrenner and Adler, 1993). The 
condition of local tissue microcirculation is thought to play an essential role in this sequence, hence the volume and type of 
fluids administered in the first hours to maintain hemodynamic stability may play an important role in preventing complications 
and avoiding severe forms of the disease (Nasr and Papachristou, 2011).  
The study explores the relationship between fluid administration in the first 48 hours and the development of local or systemic 
complications, early or late in the course of the disease, to contribute to clarifying some open questions in this subject. 
 
1. THEORETICAL FRAMEWORK  
Acute pancreatitis is, in most cases, a self-limiting and benign disease. In a variable percentage of patients, around 15% to 20% 
(Dupuis et al., 2013), complications develop that can significantly overshadow the prognosis of acute pancreatitis (Banks et al., 
2012). Reasons for this disparate evolution are not fully known and are surely multifactorial (Yang, Chen, Phillips, Windsor and 
Petrov, 2014). Fluid therapy in the first hours of disease installment, especially in the first 48 hours, seems to have some 
influence on the development of these complications in a way not yet fully understood. Hemodynamic stability and 
maintenance of euvolemia appear to be important factors in maintaining pancreatic microcirculation, preventing ischemia and 
necrosis of pancreatic tissue, one of the most severe local complication (Nasr and Papachristou, 2011). Aggressive fluid therapy 
(infusion of high fluid volumes) seems to contribute to the maintenance of the microcirculation (Janisch and Gardner, 2016). On 
the other hand, it produces excess volume in the extracellular space which also contributes to the development of complications 
(Stigliano, Sternby, de Madaria, Capurso, and  Petrov, 2017). We are far from knowing all the factors that lead to complications 
that worsen the course of acute pancreatitis. And with fluid therapy, it would be important to find a balance to avoid the 
deleterious effects of its use. 
According to the last review of Atlanta 2012 (Banks et al., 2012), acute pancreatitis complications can be divided in local and 
systemic, and they can appear early or late in the course of the disease. Local complications result from the collection of fluid in 
or around the pancreas and/or presence of pancreatic necrosis, diagnosed through CT scan (Balthazar, 2002). Both of these 
types of local collection can suffer secondary infection, which worsens the prognosis. Systemic complications refer to the 
exacerbation of pre-existing illnesses, as cardiac or respiratory disease. In this regard, it is easy to understand the influence that 
fluid therapy may have on the appearance or worsening of complications. The maintenance of euvolemia and hemodynamic 
stability are important to avoid the onset of ischemia and necrosis, requiring administration of fluid (Tenner, Baillie, DeWitt and 
Vege, 2013). On the other hand, excessive volume administration can produce tissue edema and hypervolemia, worsening pre-
existing cardiac, pulmonary or other conditions (Gardner, Vege, Pearson and Chari, 2008). Still, another aspect introduced by the 
Atlanta review was the importance of organ failure in the progress and prognosis of acute pancreatitis. In this matter, 
pancreatitis can be divided in mild, if no organ failure is present, moderate if a transient organ failure ensues (less than 48 
hours) and severe, with persistent organ failure. Pancreatic necrosis is the worst local complication possible, more so if infection 
emerges (Pereira, Constantino, Duarte, Pinho and Pinheiro, 2015). In close relation to the concept of organ failure is tissue 
oxygenation. It depends on several factors but, above all, on patient's volume state and oxygen carrying capacity. This not only 
stresses the importance of the fluid volume to administer but also its type. The need to increase volume to maintain 
hemodynamic stability, which can be accomplished with crystalloids, may be associated with the need for oxygen transport 
capacity, as erythrocyte concentrate transfusion (Kalkwarf and Cotton, 2017). 
 
2. DATA AND METHODS 
This retrospective study included all the records of the 109 patients admitted to the Surgical High Dependency Unit of Tondela 
Viseu Hospital Centre, between 2007 and 2012, with the diagnosis of acute pancreatitis (according to the Atlanta 2012 revision).  
Statistical analysis was performed using IBM SPSS Statistics (version 24). Numerical variables are described by mean±standard 
deviation (SD) or by the median and interquartile range (IQR). Categorical variables are described with percentages. For each 
complication, two groups of patients were considered: those who presented and those who did not present the complication. 
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The relationship between each complication and the variables under study was analyzed using the Mann-Whitney test for 
numerical variables and the Chi-square test, or Fisher's exact test, for categorical variables. Receiver operating characteristic 
(ROC) curves were used to relate the amount of fluid at 48 hours with the occurrence of each complication. The area under the 
curve (AUC) was used to measure the performance of the fluid quantity at 48 hours to determine the occurrence of 
complications. ROC analysis also allowed to establish cutoff values for the amount of fluid at 48h that optimally predicted the 
occurrence of complications. Logistic regression was used to assess the significance of the fluid therapy relationship with the 
occurrence of each complication, along with other significant variables, with the objective of identifying independent risk 
factors/markers to each complication. Besides the amount of fluid received at 48h, all variables with p<0.1 in the univariate 
analyses were considered to enter in the regression model. Non-significant variables were eliminated from the model. Statistical 
significance was set at p <0.05. 
Several clinical variables were considered in this study. Two clinical scores were used to assess the severity of the disease, 
Ranson, and APACHE II criteria. To assess organ failure, Marshall R (respiratory status), K (Kidney status) and C (Cardiovascular 
status) were considered. 
Other clinical variables studied were: 
- C-reactive protein (CRP); 
- Hematocrit; 
- Type of pancreatitis (edematous, necrotizing);  
- Amount of fluids administrated in the first 48 hours; 
- Etiology (ethanol, gallstones, mixed, drugs, others, unknown); 
- Glycemia (controlled, uncontrolled); 
- Comorbidities (respiratory, cardiac, haematological, endocrine, others); 
- Use of colloid (Starch, gelatine, Albumin, none); 
- Glucose containing fluid (yes, no); 
- Crystalloid (Ringer’s Lactate, Normal Sodium chloride, Normal polyelectrolytic solution) 
- Nutrition (yes, no). 
 
3. RESULTS 
The sample included 61.5% of males and 38.5% of females. Age ranged from 21 to 95 years old, with a mean of 67.9 years old 
and a standard deviation of 17.6. Table 1 summarizes the clinical characteristics of the patients. 
 
Table 1 - Clinical characteristics of the patients 
 % or mean±SD or median (IQR:25th-
75th) 
Ranson 3 (2-3) 
APACHE II 9 (6-13) 
Marshall R 1 (0-1) 
Marshall K 0 (0-1) 
Marshall C 0 (0-0) 
CRP 20.7±13.1 
Hematocrit 41.8±5.5 
Type of pancreatitis  
edematous 89,9% 
necrotizing 10,1% 
Fluids at 48h 7312.9±2280.2 
Etiology  
ethanol 25.7% 
gallstones 46.8% 
mixed 11.9% 
drugs 0.9% 
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 % or mean±SD or median (IQR:25th-
75th) 
others 2.8% 
unknown 11.9% 
Glycemia (controlled) 42.2% 
Comorbidities  
respiratory 13.8% 
cardiac 53.2% 
haematological 8.3% 
endocrine 35.8% 
others 46.8% 
Use of colloid  
Starch 17.4% 
gelatine 5.5% 
Albumin 0% 
none 77.1% 
Glucose containing fluid (yes) 97.2% 
Crystalloid  
Ringer’s Lactate 18.3% 
Normal Sodium chloride 52.3% 
Normal polyelectrolytic solution 29.4% 
Nutrition (yes) 39.4% 
 
In the following, results of the analysis will be described separately for each complication. 
 
a. Acute Local Complications 
Acute local complications included acute fluid collection and acute necrotic collection and were present in 13% of the patients. 
None of the clinical scores considered in this study, Ranson, APACHE II and Marshall scores, revealed any association with the 
existence of local complications, that is, these clinical scores could not differentiate patients with and without local 
complications. However, patients with local complications were younger (56±16 vs. 70±17 p=0.004), had higher values of 
hematocrit (45.8±5.4 vs 41.2±5.3 p=0.008) and higher values of CRP (33.3±12.7 vs 18.8±12.1, p<0.0005) and were significantly 
more frequent in patients with necrotizing pancreatitis relative to patients with edematous pancreatitis (81.8% vs 5.1%, 
p<0.0005). Furthermore, significant differences between patients with and without local complications were found in the type of 
colloid; a higher percentage of patients with no colloids used was found in patients without local complications (82.1% vs. 
42.9%, p=0.006). Moreover, among patients with local complications, the percentage of those who had Ringer’s Lactate was 
significantly higher (42.9% vs. 14.7%, p=0.037). As for the fluid therapy at 48hours, higher values were found for patients with 
local complications (10231.7±3874.4 vs. 6882.8±1562.7, p<0.0005), that is, when local complications were present, patients had 
significantly higher values of fluids administrated in the first 48 hours. 
ROC curves were used to evaluate the performance of fluid therapy at 48h to differentiate patients with and without local 
complications. The area under the ROC curve (AUC) was equal to 0.81 (95%CI 0.67 – 0.95; p<0.0005), suggesting an excellent 
discriminant performance (Hosmer and Lemeshow, 2000). ROC analysis also revealed the cutoff value of 7182 ml, as one with a 
good compromise between sensitivity (0.86) and specificity (0.66). This means that a fluid therapy above 7182 ml pinpoints 86% 
of patients with local complications, while 66% of those without local complications are identified by having a fluid therapy 
below 7182 ml. 
Resorting to logistic regression, a model was constructed to predict local complications. All variables that revealed a significant 
association with local complications (at the level of p<0.1) were included in the model at first, but were then eliminated if they 
did not reach significance in the model.  
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The final model only included the Type of pancreatitis and Fluidotherapy at 48h above 7182 ml (see Table 2). This model 
suggests that administration of more than 7182 ml of fluids in the first 48 hours is related to the occurrence of local 
complications regardless of the type of pancreatitis. 
 
Table 2 - Logistic regression model to predict local complications 
 Coef S.E. p 
Fluids at 48h>=7182 2.805 1.162 0.016 
Acute pancreatitis of type necrotizing 4.721 1.189 <0.0005 
Constant -4.758 1.130 <0.0005 
 
b. Late Local Complications 
Late complications (Pseudocyst; Walled-off necrosis) occurred in 12% of the patients and were significantly associated with: 
- Younger age (52±16 vs 70±17, p=0.001); 
- Higher CRP (31.8±15.4 vs 19.1±12.0, p=0.008) 
- Type of colloid (in 53.8% of patients with late complications no colloids were used, while this percentage rises to 80.2% 
in patients without late complications, p=0.046) 
- Type of acute pancreatitis (38.5 % of patients with late complications were of the type necrotizing, while this 
percentage is only 6.3% in patients with no late complications, p=0.003) 
- Higher values of fluids taken in the first 48 hours (9387.2±3291.3 vs. 7032.0±1968.3, p=0.012) 
The AUC for the ROC curve of the fluids administrated at 48 hours was 0.72 (95%CI 0.53 – 0.91; p<0.012), suggesting an 
acceptable discriminant ability to distinguish patients with and without late complications. The ROC curve yielded the cutoff of 
7742 ml for the amount of fluid, corresponding to a sensibility of 69.2% and a specificity of 76%. Thus, a fluid therapy above 
7742ml pinpoints 69.2% of patients with late complications, and below 7742ml identifies 76% of patients with no late 
complications. Logistic regression modeling yielded the model presented in Table 3, which demonstrates that administration of 
more than 7742 ml of fluid in the first 48 hours is associated with late complications, regardless of the type of pancreatitis. 
 
Table 3 - Logistic regression model to predict late complications 
 Coef S.E. p 
Fluids at 48h>=7742 1.791 0.676 0.008 
Acute pancreatitis of type necrotizing) 1.981 0.766 0.01 
Constant -3.189 0.558 <0.0005 
 
c. Presence of infection 
The percentage of patients with infection was 12.8% and, again, this was associated with: 
- Younger age (55±15 vs 70±17, p=0.002); 
- Type of colloid (in 57.1% of patients with infection no colloids were used, while this percentage rises to 80% in patients 
without infection, p=0.04) 
- Type of acute pancreatitis – again a higher percentage of patients with necrotizing pancreatitis was present in patients 
with infection (50% vs 4.2%, p<0.0005); 
- Higher values of fluids taken in the first 48 hours (9539.4±4274.3 vs 6984.8±1612.5, p=0.036). 
The ROC curve for the amount of fluid given in the first 48h to depict the presence of infection had an AUC equal to 0.67 (95%CI 
0.48 – 0.87; p=0.099), which is not significantly different from 0.5, meaning that there is no evidence that the amount of fluid at 
48 hours can perform better than chance discriminating the patients with and without infection. Nevertheless, the ROC curve 
was used to choose a cutoff for the amount of fluid, for which a good compromise between sensitivity and specificity could be 
obtained. The cutoff identified was of 8556 ml with a sensitivity of 57.1% and a specificity of 86.3%.  
Regression modeling yielded the model summarized in Table 4, from which we could deduce that independently of the type of 
pancreatitis, administration of more than 8556 ml of fluids in the first 48 hours is associated with the presence of infection. 
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Table 4 - Logistic regression model to predict presence of infection 
 Coef S.E. p 
Fluids at 48h>=8556 1.685 0.704 0.017 
Acute pancreatitis of type necrotizing) 2.736 0.79 0.001 
Constant -3.003 0.495 <0.0005 
 
d. Surgery Need 
Only 14 patients (12.8%) required surgery and, again, this was associated with: 
- Younger age (59±17 vs 69±17, p=0.038); 
- Type of colloid (in 57.1% of patients with need for surgery no colloids were used, while this percentage rises to 80% in 
patients without need for surgery, p=0.04) 
- Type of acute pancreatitis – again a higher percentage of patients with necrotizing pancreatitis was present in patients 
with need for surgery (50% vs. 4.2%, p<0.0005); 
- Amount of fluids taken in the first 48 hours (9712.1±4170.7 vs. 6959.3±1607.6 , p=0.005). 
Additionally, need for surgery was associated with comorbidities (other than respiratory, cardiac, hematological and endocrine), 
which were present in 21.4% of patients with need for surgery and in 50.5% in those who did not need for surgery (p=0.042).  
The AUC of the ROC curve for the amount of fluid given in the first 48h was 0.73 (95%CI 0.56 – 0.91; p<0.005), and this again 
suggests an acceptable discriminant ability to distinguish patients with and without the need for surgery. A good compromise 
between sensitivity and specificity was found for the cutoff of 7182 ml, with a sensitivity of 71.4% and specificity of 64.2%. 
Hence, of all patients needing for surgery, 71.4% received more than 7182ml of fluids in the first 48h, while 64.2% of those 
without the need for surgery received less than that amount of fluids. The final model found by logistic regression modeling is 
presented in Table 5. The final model includes only the fluids variable, which means that no other variable could increase 
significantly the model’s explanatory ability.  
 
Table 5 - Logistic regression model to predict surgery need 
 Coef S.E. p 
Fluids at 48h>=7182 1.501 0.629 0.017 
Constant -2.725 0.516 <0.0005 
 
e. Systemic Complications and death 
Systemic complications were present in 64% of the patients, while death only occurred in 11.9%. Patients with systemic 
complications had with higher values of CRP (23.7±13.4 vs. 15.0±10.4, p=0.001). No other variables revealed to be significantly 
associated with systemic complications. Concerning death, significantly higher values were found for the clinical scores. The 
APACHE II score had a median value of 12 (IQR 10-16) for the deceased, while for the survivors the median was 8 (IQR 6-12) 
(p=0.016). Ranson’s scores taken at 48h also tended to be higher in the group of deceased patients (p=0.007). In fact, the 
median value was equal to 2 (IQR 2-3) in the group of deceased patients, but only of 1 (IQR 1-2) in the group of survivors. For 
Marshall R, the median value was of 1 in both groups, but the interquartile range was 0-1 in the survivor's group and of 1-2 in 
the deceased group (p=0.009). Furthermore, CRP values were also significantly higher for the deceased patients (29.1±14.1 vs. 
19.6±12.6, p=0.013).  
Fluid therapy at 48 hours was not significantly associated with either of these two complications. Consequently, neither ROC 
curves nor logistic regression models were constructed to further explore the relation of fluid therapy at 48 hours with these 
two complications. 
 
4. DISCUSSION 
The importance of fluid therapy in acute pancreatitis cannot be overstressed and has been shown in several studies, as well as 
its relation to the development of complications (Stigliano et al. 2017). In this particular setting, literature has not been 
consensual, avoiding to give strict indications on the volume to administer because the results are quite disparate. Some authors 
advocate aggressive fluid therapy (Tenner et al. 2013) while others suggest some care and tighter surveillance (Gardner et al. 
2008; Janish et al. 2016). In this study, fluid administration in the first 48 hours revealed an association with local, acute and late 
Henriques, C., Pereira, J., Matos, A. C. & Afonso, C. (2018).  
Complications of fluidotherapy in patients with acute pancreatitis: A contribution. 
Millenium, 2(6), 23-31. DOI: https://doi.org/10.29352/mill0206.02.00160 
m6 
 
3
0
 
complications, the presence of infection and need for surgery. However, no significant relationship was observed between fluid 
therapy at 48 hours and death, nor with the occurrence of systemic complications. This, of course, raises the question of the 
“critical” value of fluids associated with each of the first four mentioned complications. Using ROC curves, cutoff values were 
found for each complication, trying to obtain a good compromise between sensitivity and specificity. For the first four 
mentioned complications, these values were between 7000 ml and 8600 ml, which means around 150 – 180 ml/hour. 
Furthermore, the binary variables defined by these cut-off values were significantly associated with the occurrence of the 
respective complication, demonstrating that exceeding these quantities in the administration of fluids at 48 hours is directly 
related to their appearance. For each complication, this association remained significant when investigated with multiple 
regression modeling. This study gives a contribution to the controversy about the effects of aggressive fluid therapy concerning 
the development of clinical complications and the need for surgery. It suggests that an aggressive fluid therapy may not be free 
from objections concerning the occurrence of some complications, which is also suggested in the literature (Mao et al., 2009). It 
is odd that no relationship was found between fluid therapy and the occurrence of death, given the importance of volume 
resuscitation in the treatment of acute pancreatitis and its association with several prognostic indicators as infection and need 
for surgery (Pereira et al., 2015). Eventually, the retrospective nature and sample size may contribute to this finding. Sample size 
and the convenience sampling procedure used in this study compromises the generalizability of the results. Indeed, this needs 
further investigation as this is an ongoing observational study, with more records being collected in other to further look into 
this matter. 
 
CONCLUSIONS 
High levels of fluid therapy in the first 48 hours were associated with the development of complications in this study, mainly 
acute local and late local complications. Also, patients with more aggressive fluid therapy had higher infection rates and needed 
more surgery in the treatment of their disease. 
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